Sanofi Pasteur to buy Acambis for £276 million
This article was originally published in Scrip
Executive Summary
Sanofi Pasteuris to buy Acambis after making a cash offer of £276 million, or £1.90 per share, for the UK-based vaccine developer. The price represents a 65% premium of Acambis's share price of £1.15 at the close of business on July 24th.